MyFinsight
Home
Blog
About
organon-logo-svg
Organon & Co. (OGN)
organon-logo-svg
Organon & Co. (OGN)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
195.37%
Quick Ratio
143.73%
Cash Ratio
43.27%
Debt to Asset Ratio
92.37%
Unit: Million (M) dollars
Assets Breakdown
Goodwill
Other assets
Accounts receivable (net of allo...
Others
Liabilities Breakdown
Long-term debt
Accrued and other current liabil...
Retained earnings
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
1,132
1,116
574
672
Accounts receivable (net of allowance for doubtful accounts of 13 in 2026 and 12 in 2025)
1,492
1,384
1,331
1,484
Inventories (excludes inventories of 273 in 2026 and 236 in 2025 classified in other assets)
1,351
1,373
1,406
1,488
Other current assets
1,136
1,059
1,033
1,056
Assets held for sale
0
0
8
-
Total current assets
5,111
4,932
4,352
4,700
Property, plant and equipment, net
1,281
1,279
1,303
1,290
Goodwill
4,153
4,153
4,153
4,680
Intangibles, net
1,112
1,099
1,130
1,340
Other assets
1,521
1,533
1,539
1,542
Noncurrent assets held for sale
0
0
390
-
Total assets
13,178
12,996
12,867
13,552
Current portion of long-term debt and short-term borrowings
74
16
16
45
Trade accounts payable
1,051
983
952
1,074
Accrued and other current liabilities
1,407
1,424
1,335
1,444
Income taxes payable
84
77
85
116
Liabilities held for sale
0
0
2
-
Total current liabilities
2,616
2,500
2,390
2,679
Long-term debt
8,479
8,553
8,628
8,783
Deferred income taxes
51
56
57
62
Other noncurrent liabilities
1,026
984
1,008
1,122
Noncurrent liabilities held for sale
0
0
32
-
Total liabilities
12,172
12,093
12,115
12,646
Common stock, 0.01 par value authorized - 500,000 issued and outstanding - 262,609 in 2026 and 260,316 in 2025
3
3
3
3
Additional paid-in capital
199
186
167
159
Retained earnings
1,352
1,253
1,109
1,318
Accumulated other comprehensive loss
-548
-539
-527
-574
Total stockholders equity
1,006
903
752
906
Total liabilities and stockholders equity
13,178
12,996
12,867
13,552
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable (net
of allowance for...
$1,492M
(0.54%↑ Y/Y)
Inventories (excludes
inventories of 273 in 2026 and...
$1,351M
(-7.08%↓ Y/Y)
Other current assets
$1,136M
(5.09%↑ Y/Y)
Cash and cash
equivalents
$1,132M
(88.98%↑ Y/Y)
Total current assets
$5,111M
(10.68%↑ Y/Y)
Goodwill
$4,153M
(-11.26%↓ Y/Y)
Other assets
$1,521M
(-3.37%↓ Y/Y)
Property, plant and
equipment, net
$1,281M
(1.18%↑ Y/Y)
Intangibles, net
$1,112M
(-18.36%↓ Y/Y)
Total assets
$13,178M
(-2.39%↓ Y/Y)
Total liabilities and
stockholders equity
$13,178M
(-2.39%↓ Y/Y)
Total liabilities
$12,172M
(-4.66%↓ Y/Y)
Total stockholders
equity
$1,006M
(37.24%↑ Y/Y)
Accumulated other
comprehensive loss
-$548M
(4.20%↑ Y/Y)
Long-term debt
$8,479M
(-3.44%↓ Y/Y)
Total current
liabilities
$2,616M
(-6.44%↓ Y/Y)
Other noncurrent
liabilities
$1,026M
(-8.47%↓ Y/Y)
Deferred income taxes
$51M
(-26.09%↓ Y/Y)
Retained earnings
$1,352M
(16.25%↑ Y/Y)
Additional paid-in capital
$199M
(43.17%↑ Y/Y)
Common stock, 0.01 par
value authorized -...
$3M
(0.00%↑ Y/Y)
Accrued and other
current liabilities
$1,407M
(-0.92%↓ Y/Y)
Trade accounts
payable
$1,051M
(-1.50%↓ Y/Y)
Income taxes payable
$84M
(-56.70%↓ Y/Y)
Current portion of
long-term debt and...
$74M
(164.35%↑ Y/Y)
Buy us a coffee